Skip to main content
  • Email Alerts
  • News
  • Lilly.com
  • Stock Info
    Expand mega menu
    Expand submenu
    Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Dividends & Stock Splits
  • Webcasts & Presentations
  • Financials
    Expand mega menu
    Expand submenu
    Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
    • Interactive Financials
    • Debt Securities
  • Individual Investors
  • Resources
    Expand mega menu
    Expand submenu
    Resources
    • Clinical Development Pipeline
    • Current Medicines
    • Executive Committee
    • Key Facts
    • 2025 Year in Review
    • Sustainability Report
  • Email Alerts
  • News
  • Lilly.com


Two Lilly scientists working in the lab

code
General

Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing

  • Read more about Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing

Lilly Confirms Date and Conference Call for Third-Quarter 2017 Financial Results Announcement

  • Read more about Lilly Confirms Date and Conference Call for Third-Quarter 2017 Financial Results Announcement

Humalog® Junior KwikPen® Now Available in the U.S. for People with Diabetes

  • Read more about Humalog® Junior KwikPen® Now Available in the U.S. for People with Diabetes

Additional Delivery of Insulin Ready for Distribution in Puerto Rico

  • Read more about Additional Delivery of Insulin Ready for Distribution in Puerto Rico

U.S. Patent and Trademark Office Rules In Lilly's Favor On Alimta Vitamin Regimen Patent

  • Read more about U.S. Patent and Trademark Office Rules In Lilly's Favor On Alimta Vitamin Regimen Patent

Lilly MONARCH 3 Study Published in Journal of Clinical Oncology Demonstrates Benefit of Verzenio™ (abemaciclib) Plus NSAI in Advanced Breast Cancer

  • Read more about Lilly MONARCH 3 Study Published in Journal of Clinical Oncology Demonstrates Benefit of Verzenio™ (abemaciclib) Plus NSAI in Advanced Breast Cancer

Pagination

  • Previous page ‹‹
  • Page 97
Subscribe to General
Diversity
Contact
Suppliers
Login
Terms of Use
Privacy Statement
Consumer Health Privacy Notice
Accessibility Statement
Sitemap

To speak to customer support:
Call (800) 545-5979

Your Privacy Choices logo Your Privacy Choices

Cookie Settings

Copyright © 2026 Eli Lilly and Company. All rights reserved.
Twitter Facebook Instagram LinkedIn YouTube
Terms of Use Privacy Statement Consumer Health Privacy Notice Accessibility Statement Sitemap